Viewing Study NCT03700359

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2026-02-25 @ 8:31 PM
Study NCT ID: NCT03700359
Status: UNKNOWN
Last Update Posted: 2019-11-29
First Post: 2018-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None extensive-stage small-cell lung cancer View
None lobaplatin/etoposide View
None Anlotinib maintenance therapy View